Date:9/1/2009

es to access and enforce intellectual property needed for the collaboration; the costs and requirements of regulatory compliance and the speed with which approvals are received; public acceptance of biotechnology products; and other risks and factors detailed in the company's most recent periodic report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this presentation. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.

    Contact  Media:  Riddhi Trivedi-St. Clair, Monsanto (314-694-4490)
                     Sylvie Delassus, Cellectis (+331 4183 9900)
                     Caroline Carmagnol, ALIZE RP  (+33 6 64 18 99 59)

'/>"/>

SOURCE Monsanto Company Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Monsanto Is on the Verge of a Technology Explosion, Executives Tell Investors at Annual Field Event
2. Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres
3. Monsanto, BASF Scientists Disclose Discovery of Gene Conferring Drought Tolerance in Corn Plants
4. Monsantos Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment
5. Monsanto Executives to Discuss Companys Growth Drivers, Profit Goals at Investor Conferences in February
6. BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies
7. Monsanto Shareowners Reelect Board Members at Companys Annual Meeting
8. Monsanto Board Approves 10 Percent Dividend Increase
9. Monsanto Recognized as Top Biotechnology Employer by Science Magazine
10. Monsanto Sees Growing Opportunity for Biotech Traits Globally
11. New Insect Protection Technology From Monsanto Company Deregulated by USDA